The Boehringer Ingelheim Foundation honours particularly outstanding scientific achievements with its science awards. Endowed with 100,000 euros, the Heinrich Wieland Prize honours distinguished scientists from around the world for their groundbreaking research on biologically active molecules and systems in the fields of chemistry, biochemistry, and physiology, as well as their clinical importance. Four of the Prize’s laureates have been subsequent Nobel Prize laureates.
The Foundation awards the Boehringer Ingelheim Prize to excellent and advanced early-career scientists at the University Medical Center of the University of Mainz. It has been presented annually since 1969 for excellence in clinical as well as theoretical medicine, and is endowed with a total of 30,000 euros in prize money.
Each year, the Foundation awards four PhD student prizes at the University of Mainz in recognition of particularly excellent dissertations or theses in biology, medicine, chemistry, and pharmacy.
2020 Heinrich Wieland Prize.
Professor Craig M. Crews of Yale University in New Haven, Connecticut, USA, will receive the 2020 Heinrich Wieland Prize for pioneering protein degradation as a new principle in pharmacology. His research has opened the way for entirely new treatment options for numerous diseases, including certain types of cancer. Due to the COVID-19 pandemic, the formal award ceremony and scientific symposium have been postponed until 2021.
At Starting up science: From lab to therapy, a virtual event held as part of Berlin Science Week on 2 November 2020, Professor Crews met with Professor Christian Hackenberger in Berlin and Professor Tüttenberg in Mainz to discuss how ideas spawned from curiosity-driven research can pave the way for new therapeutic approaches and how science start-ups can succeed.
You can find more information about the event at Heinrich Wieland Prize 2020.
2020 Boehringer Ingelheim Prize.
PD Dr Maximilian Ackermann receives the Boehringer Ingelheim Prize for clinical medicine for showing that the development of new blood vessels play an important role in certain lung diseases.
Dr Christine Zimmermann is awarded the Boehringer Ingelheim Prize for theoretical medicine for her discovery that human cells can curb the replication of certain viruses via autophagy, the mechanisms cells use for degrading and digesting cell components. This knowledge is of high clinical relevance as it allows to find better treatment and develop drugs for people most at risk from viral infections.